Amon Kipruto Mely was only 22 when he made a decision that would leave him struggling with consequences he never expected. In western Kenya, someone offered him thousands of dollars for one of his kidneys.
He had spent years searching for financial stability, moving between jobs without finding a reliable income. Like many young people facing poverty, Amon wanted an opportunity to build a better future for himself and his family.
Then a friend introduced an extraordinary proposition. Amon could sell one kidney and receive $6,000, an amount that seemed capable of changing his circumstances. At first, he repeatedly refused to consider the offer.
Eventually, the possibility of escaping financial hardship overcame his reluctance. He agreed to meet the people arranging the transaction, unaware of the disturbing questions that would later surround the international transplant operation.
A middleman brought him to Mediheal Hospital in Eldoret, a Kenyan city that would become the center of an international investigation. According to Amon, an Indian medical team received him and began preparing him for surgery.
He worried about the dangers of losing a kidney, but claimed nobody properly explained the medical consequences. Instead, the intermediary pointed toward other supposed donors and reassured him that they had recovered and returned to work.
Medical workers collected blood and tissue samples to determine whether he could donate. Amon also encountered the intended recipient, whom he described as an elderly Somali woman waiting for a kidney transplant at the facility.
Before the operation, two doctors asked him to sign documents written in English. Amon said he did not understand what the papers contained, raising serious questions about whether he had provided genuinely informed consent.
One doctor reportedly questioned his age after learning he had just turned 22. Despite that concern, Amon said he was reassured that everything would be fine, and the preparations for surgery continued.
After the operation, the promise of $6,000 collapsed. Amon said he received only $4,000 before being sent home following a short recovery period. The money was already considerably less than he had expected.
He purchased a phone and a car, hoping those belongings might help him establish a better life. But the vehicle soon broke down, and the financial security he had imagined never materialized.
Then his physical condition deteriorated. He struggled to eat, experienced dizziness and abdominal pain, and eventually fainted. His mother, Leah Metto, rushed him to a hospital, frightened by the sudden decline in his health.
There, doctors explained that her son was missing a kidney. Leah was devastated. She had never been consulted about his decision and only discovered what had happened after he became seriously ill.
Amon’s experience was not isolated. Investigators working with DW Documentary, Der Spiegel, and ZDF uncovered accounts from other young Kenyan men who described remarkably similar experiences involving kidney sales and transplant procedures at Mediheal.
In the town of Oyugis, researcher Willis Okumu had been examining reports of young men selling their kidneys. His work, connected with an Interpol-supported project, brought him into contact with people who described exploitation.
Four men told investigators they had undergone kidney removal procedures at Mediheal during the previous three years. They claimed they had received inadequate explanations of the risks and accepted the arrangements because they needed money.
Each reported receiving approximately $2,000. One had dreamed of building a house, while another bought a motorcycle on credit. When he struggled to repay the loan, creditors eventually took the motorcycle away.
Some of the men also alleged that recruiters offered approximately $400 for introducing additional kidney sellers. That financial incentive, if accurately described, helped explain how vulnerable young people could be drawn into the same system.
Okumu believed the operations exploited poverty and limited economic opportunities. He also described donors experiencing depression, financial disappointment, and persistent health problems that could interfere with their ability to earn a living.
A former longtime Mediheal employee offered investigators another perspective. According to this source, the transplant business had expanded beyond its earlier arrangements involving Kenyan donors and Somali recipients into a much broader international operation.
The former employee alleged that recipients from Israel began arriving in 2022, followed later by patients from Germany. Donors were reportedly brought from countries including Azerbaijan, Kazakhstan, and Pakistan to participate in transplant procedures.
According to the source, some donors signed documents falsely presenting them as unpaid relatives of their recipients. Language barriers allegedly prevented some individuals from understanding the declarations they were being asked to sign.
The employee also described troubling medical practices, including transplants involving unusually elderly recipients and patients facing significant risks. One recipient allegedly died during surgery, while another reportedly experienced life-threatening complications afterward.
Most strikingly, the former employee claimed some international recipients paid approximately $200,000 for a kidney transplant. That figure stood in devastating contrast to the few thousand dollars reportedly received by vulnerable donors.
Investigators began examining MedLead, an organization promoting international kidney transplantation. Its website advertised rapid access to procedures, presented donors as altruistic, and claimed that its operations complied with applicable organ donation laws.
The organization also promoted testimonials from patients who described successful procedures. One German woman, Sabine Fischer-Kugler, had spent decades living with kidney disease and faced the possibility of another lengthy wait for transplantation.
She had received her first transplanted kidney at 25, which functioned for approximately 30 years. When her body began rejecting it, she searched for another option as her medical circumstances became increasingly desperate.
Germany’s limited supply of donor organs created another obstacle. Some patients could face waiting periods of eight to ten years, while Sabine’s husband was incompatible and her adult son was considered too young.
After discovering MedLead online, Sabine believed its professional-looking website and contractual arrangements offered a legitimate solution. She understood that her payment would go through the organization rather than directly to an individual kidney donor.
She eventually traveled to Kenya and received a kidney from a 24-year-old man from Azerbaijan. Although she briefly met him, she knew little about his circumstances or whether he received compensation.
Sabine acknowledged that paying for a kidney raised troubling ethical questions. However, she believed the contractual structure protected her legally because she had not personally transferred money to the donor.
The documentary challenged that assumption. Under German law, a recipient can potentially face criminal prosecution if a transplanted organ has been unlawfully purchased, even when payment passes through an intermediary organization.
The investigation subsequently examined Robert Shpolanski, identified as the head of MedLead. His name appeared in a 2016 Israeli indictment concerning an alleged international network involved in unlawful kidney transplant arrangements.
The indictment accused him of involvement in a network reportedly headed by Boris Wolfman, which authorities associated with illegal transplantation activities across several countries. These were allegations, not proof that every accusation had been established.
Shpolanski denied having any connection with Wolfman. In correspondence with the investigating news organizations, MedLead also denied recruiting donors and maintained that its activities were transparent, lawful, and based entirely on altruistic donations.
Meanwhile, investigators visited Eldoret and secretly recorded conversations involving foreign patients. At a hotel reportedly used by transplant recipients, they encountered people from several countries who had traveled to Kenya seeking kidney procedures.
One Russian couple described awaiting medical test results. An Israeli family spoke positively about arrangements for their daughter’s transplant, while another Israeli patient raised questions about the identity and circumstances of his prospective donor.
A 72-year-old Israeli man described uncertainty surrounding the process and suggested that a supposedly familial relationship might be presented to justify his transplant. His comments highlighted concerns about how donor relationships were documented.
Medical specialists were also raising alarms. Dr. Jonathan Wala, who headed the Kenya Renal Association, described reports of transplant recipients returning with severe infections, complications around transplanted kidneys, and organs that eventually stopped functioning.
The documentary identified a particularly significant development: a 2023 fact-finding mission conducted by Kenya’s Blood Transfusion and Transplant Service had already examined conditions at Mediheal and documented serious concerns about transplant practices.
The investigation found that recipients and donors were frequently unrelated. It also described procedures performed despite poor compatibility results, alongside high-risk transplants involving patients with cancer or extremely advanced ages.
The report additionally noted that foreign donor and recipient surgeries involved cash transactions. Its recommendations called for the organ trafficking allegations to be investigated and for another inspection to take place within three months.
Yet according to the documentary, the report was never publicly released and its recommendations were not implemented. This raised an urgent question about why serious concerns had failed to produce effective regulatory intervention.
A criminal investigator working on organ trafficking cases in Eldoret described formidable obstacles. He alleged that illegal transplant activities extended beyond one hospital and involved approximately two or three medical facilities.
The investigator said his findings had been forwarded to prosecutors without receiving a meaningful response. He believed powerful outside interests could interfere with investigations and expressed genuine fears about his personal safety.
Several sources alleged that influential figures within Kenya’s political establishment protected the lucrative transplant business. However, those allegations required independent investigation and could not be treated as established findings of government involvement.
The documentary examined Swarup Mishra, Mediheal Group’s founder and chairman, a former Kenyan parliamentarian. It highlighted his political connections and appointment to a national vaccine institute despite continuing public allegations surrounding the hospital group.
Mishra did not respond to repeated interview requests from the journalists, according to the documentary. His lack of response left important questions unanswered, but it did not independently establish responsibility for any alleged trafficking activity.
Back in western Kenya, Amon and his mother continued living with the consequences. Leah said she had reported what happened to the police but never received a meaningful update about the investigation involving her son.
Amon, still only 22 when interviewed, described being unable to lift heavy objects or perform physical labor. His mother struggled to support him financially while also meeting the educational expenses of his younger sister.
The family had previously imagined a different future. Before the kidney operation, Amon had been preparing an application connected with employment in Egypt, representing another possible route toward financial stability and independence.
Now, rather than pursuing that opportunity, he was coping with serious health problems and profound regret. He said that, given another chance, he would never agree to surrender his kidney, regardless of the promises.
His experience exposed a painful contradiction at the heart of the alleged trafficking operation. Wealthier recipients could reportedly pay extraordinary sums for desperately needed organs while economically vulnerable donors received comparatively little and faced lasting consequences.
The investigation ultimately presented a network of allegations involving recruitment, medical institutions, international intermediaries, questionable consent procedures, and possible failures of oversight. It also documented denials from parties accused of participating in unlawful arrangements.
For Amon, however, the most immediate consequences were painfully personal. He had hoped that selling a kidney would help him escape poverty. Instead, he faced financial hardship, diminished physical capacity, and deep regret.
The documentary ended without establishing that the entire alleged network had been dismantled or that every implicated party had been held accountable. The unresolved allegations demanded investigation, while the suffering described by donors remained impossible to dismiss.
